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Supplementary material 
Figure S1. Intensities of deconvoluted MtSK MS spectra vs preincubation time with IQ. 
MtSK (1µM) was incubated for 30 hours with 100 µM IQ at 4oC. Intensities of the deconvoluted 
MS spectra were plotted against preincubation time. With increasing preincubation time, a 
decrease in the intensities of both forms of free MtSK (19648.68 and 19517.73 Da with and 
without N-terminal methionine, respectively) was observed suggesting the formation of IQ-
adducts (A). Increase of both forms of singly modified (MtSK-IQ) enzyme (19975.18 and 
19843.75 Da with and without N-terminal methionine, respectively) was observed reaching a 
maximum intensity at around 15 hours (B). Increase of doubly modified (MtSK-IQ2) enzyme 
(20301.29 and 20170.19 Da with and without N-Terminal methionine) was observed reaching a 
maximum intensity at around 20 hours (C). 
Figure S2. Deconvoluted ESI-MS spectra for MtSK incubated with 10 µM IQ.  MtSK (1.0 
µM) was incubated with 10 µM IQ for 30 hours at 4 °C prior to LC separation and MS analyses 
of the intact protein. Representative overlapped chromatograms of control MtSK sample (blue 
line) and MtSK+IQ sample (red line) are shown in panel A. The deconvoluted mass spectrum 
corresponding to the entire elution envelop (5.16 – 6.62 min) (B) is compared to that of the first 
(5.16 – 5.44 min) (C), second (5.44 – 5.84 min) (D), and third (5.84 – 6.62 min) (E) elution 
features of the chromatogram. Masses of 19648.97 and 19517.73 in panel B represent intact 
MtSK with and without its N-terminal methionine, respectively. Each deconvoluted mass in 
panels D and E corresponds to addition of an IQ derivative with a mass shift of 326 Da.  
Figure S3. IQ inhibition of LDH, PK, and MtKatG activities according to their respective 
spectrophotometric assays. LDH (A), PK (B) and MtKatG (C) were preincubated with 100 µM 
IQ for 1 hr at 25 °C. Reactions were initiated by the addition of preformed enzyme-inhibitor to 
the appropriate assay cocktail for each enzyme (see Materials and Methods). LDH (A) and PK 
(B) activities were monitored by decrease in absorbance at 340 nm due to NADH oxidation.
MtKatG activity was monitored by decrease in absorbance at 240 nm due to H2O2 consumption.
Figure S4. Deconvoluted ESI-MS spectra for PK incubated with 100 µM IQ.  PK (1.0 µM) 
was incubated with 100 µM IQ for 30 hours at 4 °C prior to LC separation and MS analyses of 
the intact protein. The entire deconvoluted mass spectrum (A) of the control (1 hr) and sample 
(IQ 30 hr) from 6 – 6.8 min shows unmodified PK with molecular weight of 58020 Da. No mass 
shifts were observed post incubation. Spectra within 7 – 8 min range had high intensities of 
background noise and were not included. 
Figure S5. Deconvoluted ESI-MS spectra for LDH incubated with 100 µM IQ.  LDH (1.0 
µM) was incubated with 100 µM IQ for 30 hours at 4 °C prior to LC separation and MS analyses 
of the intact protein. Overlapped chromatograms of control LDH sample and LDH+IQ sample 
are represented in green and black lines respectively.  The corresponding chromatograms from 6 
– 7.5 min of LDH (A) and LDH+IQ (A) show mainly unmodified protein. Deconvoluted mass
spectra corresponding to the peaks eluding at 6.0 – 6.5 min of LDH+IQ shows a preponderance
of the unmodified protein (36461 Da) (B).  Deconvoluting the LDH+IQ mass spectra from 6.5 –
© 2018. This manuscript version is made available under the CC-
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7.5 min shows the masses of both unmodified (36461 Da) and IQ-modified (36789) LDH (C), 
with a net mass difference of 326 Da.  
Figure S6. Identification of Lys 15, Ser 44, Thr 111, and Ser 77 IQ-adducted peptides by 
nano-LC-ESI MS/MS analysis. MS/MS spectra of the peptide AVLVGLPGSGKSTIGRR [M 
+ 3H]+3 m/z 665.43, unmodified y-ion series up to y6*+ and shifted by 326.3 from y7. Likewise, 
b-ion series are unmodified up to b10+ and shifted by 326.3 from b11*, depicting Lys15 as the 
residued modified by IQ (A). MS/MS spectra of the peptide SIADIFATDGEQEFR [M + 2H]+2 
m/z 1013.05, shows and unmodified y-ion series and a b-ion series shifted by 326.3 from b1*2+, 
identifying Ser 44 as the modification site adducted by ilimaquinone (B). MS/MS spectra of the 
peptide TGGNTVRPLLAGPDR [M + 2H]+2 m/z 925.56, shows and unmodified y-ion series and 
a b-ion series shifted by 326.3 from b1*2+, identifying Thr 111 as the modification site adducted 
by ilimaquinone (C). MS/MS spectra of peptide AALADHDGVLSLGGGAVTSPGVR [M + 
3H]+3 m/z 816.10 shows an unmodified y-ion series up to y12*+ and shifted by 326.3 from y13. 
Likewise, b-ion series are unmodified up to b10+ and shifted by 326.3 from b11*, depicting Ser77 
as the residued modified by IQ (D). 
 
 
3 
 
 
 
Figure S1 
4 
 
Figure S2 
 
R
e
la
ti
v
e
 I
n
te
n
s
it
y
4 5 6 7 8 9 1 0
0
5 0
1 0 0
1 5 0
C o n tro l 1  h r
IQ  3 0  h r
B
C D E
R e te n tio n  T im e  (m in )
R
e
la
ti
v
e
  
A
b
u
n
d
a
n
c
e
A
0
5 0
1 0 0
1 9 5 1 7 .5 9 B1 9 6 4 8 .8 0
0
5 0
1 0 0
1 9 5 1 7 .6 0
D1 9 8 4 4 .2 8
3 2 7
1 9 9 7 5 .2 2
D e c o n v o lu te d  M a s s  (D a )
1 9 0 0 0 1 9 5 0 0 2 0 0 0 0 2 0 5 0 0 2 1 0 0 0
0
5 0
1 0 0
1 9 5 1 7 .6 8
E
1 9 6 4 7 .2 0 1 9 8 4 4 .2 7
3 2 6 .5 9 1 9 9 7 0 .6 2
0
5 0
1 0 0
1 9 5 1 7 .5 3 C1 9 6 4 8 .6 8
5 
 
 
 
 
 
 
 
Figure S3 
 
 
 
 
 
 
 
6 
 
 
4 6 8 10
0
50
100
150
Control 1 hr
IQ 30 hr
A
Retention Time (min)
R
el
at
iv
e
A
bu
nd
an
ce
0
50
100
57200.31
A58020.27
59096.16
Control 1 hr
In
te
ns
ity
Deconvoluted Mass (Da)
55000 60000 65000
0
50
100
57198.01
A58020.22
59088.39
IQ 30 hr
 
Figure S4 
7 
 
0
50
100
36461.54 A
IQ 7 hr
0
50
100
36461.54 B
IQ 7 hr
34000 35000 36000 37000 38000 39000
0
50
100 C
36789.35
36461.89
IQ 7 hr
In
te
ns
ity
Deconvoluted Mass (Da)
0
50
100 A36461.54
Control 1 hr
A
B C
4 6 8 10
0
50
100
150
IQ 7 hr
Control 1 hr
Retention Time (min)
Re
la
tiv
e
A
bu
nd
an
ce
 
Figure S5 
8 
 
 
Figure S6 
